Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy

Breast Cancer Research and Treatment

Volumn 91, Issue 3, 2005, Pages 217-225

  Ryberg, Marianne ^a,b   Nielsen, Dorte ^a   Osterlind, Kell ^a   Andersen, Per Kragh ^b   Skovsgaard, Torben ^a   Dombernowsky, Per ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Breast cancer; CNS metastases; Competing risk analysis; Epirubicin; Lactate dehydrogenase; Predictive factor

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; LACTATE DEHYDROGENASE; VINDESINE;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CONTROLLED STUDY; FOLLOW UP; HEART FAILURE; HUMAN; KAPLAN MEIER METHOD; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; STATISTICAL ANALYSIS; SYSTEMIC DISEASE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CISPLATIN; EPIRUBICIN; FEMALE; HUMANS; INCIDENCE; L-LACTATE DEHYDROGENASE; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; RISK FACTORS; VINDESINE;

EID: 21244481753     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-0323-x     Document Type: Article

References (28)

1. BP Posner NL Chernik 1978 Intracranial metastases from systemic cancer Adv Neurol 19 579 591
2. A Goldhirsch RD Gelber M Castiglione 1988 Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: Pattern and prognosis J Clin Oncol 6 89 97
3. C Kamby J Andersen B Ejlertsen NE Birkler L Rytter K Zedeler C Rose 1991 Pattern of spread and progression in relation to the characteristics of the primary tumour in human breast cancer Acta Oncol 30 301 308
4. W Boogerd VW Vos AAM Hart G Baris 1993 Brain metastases in breast cancer: Natural history, prognostic factors and outcome J Neurooncol 15 165 174
5. S De la Monte GM Hutchins GW Moore 1988 Influence of age on the metastatic behavior of breast carcinoma Human Pathol 19 529 534
6. AHG Paterson M Agerwal A Lees O Hanson J Szafran 1982 Brain metastases in breast cancer patients receiving adjuvant chemotherapy Cancer 49 651 654
7. YUT Lee 1989 Breast carcinoma: pattern of recurrence and metastasis after mastectomy Am J Clin Oncol 7 443 449
8. A Distephano Y Young GN Hortobagyi GR Blumenschein 1979 The natural history of breast cancer patients with brain metastases Cancer 44 1913 1918
9. D Crivellari O Pagani A Veronesi D Lombardi F Nole' B Thurlimann D Hess M Borner J Bauer G Martyinelli R Graffeo C Sessa A Goldhirsch 2001 High incidence of central nervous system involvement in patients with metastastic or locally advanced breast cancer treated with epirubicin and docetaxel Ann Oncol 12 353 356
10. Y Tsukada A Fouad JW Pickren 1983 Central nervous system metastases from breast carcinoma. Autopsy study Cancer 52 2349 2354
11. FB Hagemeister AU Buzdar MA Luna GR Blumenschein 1980 Causes of death in breast cancer. A clinicopathological study Cancer 46 162 167
12. M Ryberg D Nielsen T Skovsgaard J Hansen BV Jensen P Dombernowsky 1998 Epirubicin cardiotoxicity: An analysis of 469 patients with metastatic breast cancer J Clin Oncol 16 3502 3508
13. RJ Gray 1988 A class of k-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1141 1154
14. TA Gooley W Leisenring J Crowley BE Storer 1999 Estimation of failure probabilities in the presence of competing risks: New representations of old estimators Stat Med 18 695 706
15. PK Andersen ZS Abildstrom S Rosthoej 2002 Competing risks as a multi-state model StatMeth Med Res 11 203 204
16. D Nielsen P Dombernowsky T Skovsgaard J Jensen E Andersen SA Engelholm M Hansen 1990 Epirubicin or epirubicin and vindesine in advanced breast cancer. A phase III study Ann Oncol 1 275 280
17. D Nielsen SK Larsen OP Hansen TS Skovsgaard 2000 Epirubicin or epirubicin and cisplatin as first line treatment in advanced breast cancer Cancer Chemother Pharmacol 46 459 466
18. GN Hortobagyi TL Smith KD Legha 1983 Multivariate analysis of prognostic factors in metastatic breast cancer J Clin Oncol 1 776 786
19. M Ryberg D Nielsen K Osterlind T Skovsgaard P Dombernowsky 2001 Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy Ann Oncol 12 81 87
20. FJ Lagerwaard PC Levendag PJCM Novak WMH Eijkenboom PEJ Hanssens PIM Schmitz 1999 Identification of prognostic factors in patients with brain metastases: A review of 1292 patients Int J Radiation Biol Phys 43 795 803
21. KD Miller T Weathers LG Hanley 2001 Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on the overall survival Breast Cancer Res Treat 3 240
22. W Boogerd O Dalesio EM Bais JJ Sande van der 1992 Response of brain metastases from breast cancer to systemic chemotherapy Cancer 69 972 980
23. D Rosner T Nemoto WW Lane 1986 Chemotherapy induces regression of brain metastases in breast carcinoma Cancer 58 832 839
24. JR Anderson KC Cain RD Gelber 1983 An analysis of survival by tumor response J Clin Oncol 1 710 719
25. C Redmond B Fisher S Wieand 1983 The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival Cancer Treat Rep 67 519 526
26. C Cordon-Cardo JP O'Brien J Boccia BD Casals JR Bertino MR Melamed 1990 Expression of the multidrug resistance gene product (P-Glycoprotein) in human normal and tumor tissues J Histochem Cytochem 38 1277 1287
27. A Auperin R Arriagada JP Pignon C Peucoux A Gregeor RJ Stephens P Kristjansen BE Johnson H Ueoka H Wagner J Aisner 1999 Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission N Engl J Med 341 476 84
28. M Stuschke W Eberhardt C Pottgen G Stamatis H Wilke G Stuben F Stoblen HH Wilhem H Menker H Teschler RD Muller V Budach S Seeber H Sack 1999 Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long term follow-up and investigations of late neuropsychologic effects J Clin Oncol 17 2700 2709